Cardioprotective Effects of KR-30450, a Novel K^+_<ATP> Opener, and Its Major Metabolite KR-30818 on Isolated Rat Hearts

Access this Article



The cardiac effects of KR-30450 ((-)-(2<I>R</I>)-2-([1, 3]-dioxolan-2-yl)-2-methyl-4-(2-oxopyrrolidin-1-yl)-6-nitro-2<I>H</I>-1-benzopyran), a newly synthesized potassium channel activator, and its major metabolite KR-30818 ((-)-(2<I>R</I>)-2-hydroxymethyl-2-methyl-4-(2-oxopyrrolidin-1-yl)-6-nitro-2<I>H</I>-1-benzopyran) were compared with those of lemakalim, a prototype of this class, in isolated globally ischemic rat hearts. KR-30450 and KR-30818 significantly improved reperfusion cardiac function (LVDP, left ventricular developed pressure; double product, LVDP×heart rate/1000), their potency being 5.2-fold and 0.7-fold greater than lemakalim (ED<SUB>50</SUB> for recovering predrug double product: 0.10, 0.80 and 0.54 μM, respectively). KR-30450 and KR-30818 significantly attenuated reperfusion contracture and lactate dehydrogenase release with potency greater than and equal to lemakalim, respectively. They significantly increased time to contracture (TTC) during ischemia in a dose-dependent manner with a greater potency than lemakalim (EC<SUB>25</SUB> for increasing TTC: 1.2, 2.1 and 3.2 μM, respectively). The protective effects of three compounds on the measured parameters were reversed by glyburide, a selective K<SUP>+</SUP><SUB>ATP</SUB> blocker. In non-ischemic hearts, KR-30450 and lemakalim exerted weak negative inotropism at high concentrations and KR-30818 had no effects, whereas the three compounds significantly increased coronary flow at doses studied. Glyburide completely reversed preischemic cardiodepressant effects of these compounds but not their effects on coronary flow. In conclusion, KR-30450, a recently developed K<SUP>+</SUP><SUB>ATP</SUB> opener, exerted more potent cardioprotective effects than lemakalim, and its major metabolite KR-30818 may play a significant role in its action in vivo.


  • The Japanese Journal of Pharmacology

    The Japanese Journal of Pharmacology 76(1), 65-73, 1998-01

    The Japanese Pharmacological Society

References:  25

Cited by:  4


  • NII Article ID (NAID)
  • Text Lang
  • Article Type
    Journal Article
  • ISSN
  • NDL Article ID
  • NDL Source Classification
  • NDL Call No.
  • Data Source
    CJP  CJPref  NDL  J-STAGE 
Page Top